SDCCQ250117C1000
- 6.25
- 0.000.00%
SmileDirectClub Newsroom
SmileDirectClub (SDC) Gets a Sell From Bank of America Securities
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Alector (ALEC) and SmileDirectClub (SDC)
Bank of America Securities Remains a Sell on SmileDirectClub (SDC)
UBS Adjusts SmileDirectClub Price Target to $0.50 From $1.20, Maintains Neutral Rating
Loop Capital Upgrades SmileDirectClub to Hold From Sell, $1 Price Target
SmileDirectClub Price Target Cut to $0.90/Share From $1.15 by Morgan Stanley
SmileDirectClub Is Maintained at Equal-Weight by Morgan Stanley
Morgan Stanley Maintains Equal-Weight on SmileDirectClub, Lowers Price Target to $0.9
Stephens Adjusts Price Target on SmileDirectClub to $2 From $3, Keeps Equalweight Rating
Morgan Stanley Trims SmileDirectClub's Price Target to $1.15 From $2, Maintains Equalweight Rating
SmileDirectClub Price Target Cut to $1.15/Share From $2.00 by Morgan Stanley
SmileDirectClub Is Maintained at Equal-Weight by Morgan Stanley
Morgan Stanley Maintains Equal-Weight on SmileDirectClub, Lowers Price Target to $1.15
UBS Adjusts SmileDirectClub Price Target to $1.25 From $2, Maintains Neutral Rating
Stifel Trims SmileDirectClub's Price Target to $1 From $2, Hold Rating Kept
SmileDirectClub Is Maintained at Hold by Stifel
SmileDirectClub Price Target Cut to $1.00/Share From $2.00 by Stifel
Stifel Maintains Hold on SmileDirectClub, Lowers Price Target to $1
Morgan Stanley Adjusts SmileDirectClub Price Target to $2 From $2.20, Maintains Equal Weight Rating
SmileDirectClub Is Maintained at Equal-Weight by Morgan Stanley